Rafarma Pharmaceuticals Inc [Wy] (RAFA)

$0.05 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 10,700
Avg Vol 38,630
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 17%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreemen...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 801-210-7135
Website: rafarma.si
Address:
49 West 9000 South, Suite 1, Sandy, United States
Nanoman1
Nanoman1 Jun. 24 at 1:24 PM
$RAFA Rafarma Pharmaceuticals, USA @RAFArma_Pharma 4h Topic: Liza Petrova's Zoom Meeting Time: Jun 26, 2025 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://us06web.zoom.us/j/88241524183?pwd=YJjztaHFbMIV6IC7j1wdNxbBa7KOb1.1 Meeting ID: 882 4152 4183 Passcode: 6udSUG
0 · Reply
pa600a
pa600a Jun. 24 at 12:04 PM
$RAFA https://x.com/rafarma_pharma/status/1937469979596624374?s=61
0 · Reply
Simmer20
Simmer20 May. 30 at 10:00 PM
$RAFA Compete Scam
1 · Reply
pa600a
pa600a May. 29 at 12:23 PM
$RAFA
1 · Reply
Nanoman1
Nanoman1 May. 14 at 10:42 AM
$RAFA They just filed their management certification and attorney letter for end of 2024 with OTCMarkets. Stock is starting to respond. https://www.otcmarkets.com/stock/RAFA/disclosure
0 · Reply
pa600a
pa600a Apr. 30 at 1:59 PM
$RAFA Topic: RAFArma Time: Apr 30, 2025 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://us06web.zoom.us/j/81166947770?pwd=kR6jJmpYama8DQZbgY5OQPby4PA1IZ.1 Meeting ID: 811 6694 7770 Passcode: 8ieuNi --- One tap mobile +15642172000,,81166947770#,,,,*856462# US +16465588656,,81166947770#,,,,*856462# US (New York) --- Dial by your location • +1 564 217 2000 US • +1 646 558 8656 US (New York) • +1 646 931 3860 US • +1 669 444 9171 US • +1 689 278 1000 US • +1 719 359 4580 US • +1 720 707 2699 US (Denver) • +1 253 205 0468 US • +1 253 215 8782 US (Tacoma) • +1 301 715 8592 US (Washington DC) • +1 305 224 1968 US • +1 309 205 3325 US • +1 312 626 6799 US (Chicago) • +1 346 248 7799 US (Houston) • +1 360 209 5623 US • +1 386 347 5053 US • +1 507 473 4847 US Meeting ID: 811 6694 7770 Passcode: 856462 Find your local number: https://us06web.zoom.us/u/kkl0XK1F4
0 · Reply
pa600a
pa600a Apr. 25 at 4:10 AM
$RAFA .071 close and the future market cap of roughly $2 billion once the company restructuring has been completed. Previous estimate December 2025 from management. Stay tuned!
0 · Reply
Nanoman1
Nanoman1 Mar. 14 at 1:37 AM
$RAFA Presentation Slides from Virtual Conference 3/13/2025 https://on24static.akamaized.net/event/48/96/44/2/rt/1/documents/resourceList1741808535823/rafarmapharmaceuticals20251741808535823.pdf
1 · Reply
pa600a
pa600a Mar. 12 at 8:12 PM
$RAFA https://finance.yahoo.com/news/rafarma-pharmaceuticals-present-virtual-life-152300520.html
0 · Reply
Nanoman1
Nanoman1 Mar. 12 at 7:50 PM
$RAFA Life Sciences Investor Forum Agenda Announced for March 13th Press Release | 03/12/2025 NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum March 13th. This event is co-hosted by Zacks Small Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/4hnure6 https://www.otcmarkets.com/stock/RAFA/news?id=470330
0 · Reply
Latest News on RAFA
No data available.
Nanoman1
Nanoman1 Jun. 24 at 1:24 PM
$RAFA Rafarma Pharmaceuticals, USA @RAFArma_Pharma 4h Topic: Liza Petrova's Zoom Meeting Time: Jun 26, 2025 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://us06web.zoom.us/j/88241524183?pwd=YJjztaHFbMIV6IC7j1wdNxbBa7KOb1.1 Meeting ID: 882 4152 4183 Passcode: 6udSUG
0 · Reply
pa600a
pa600a Jun. 24 at 12:04 PM
$RAFA https://x.com/rafarma_pharma/status/1937469979596624374?s=61
0 · Reply
Simmer20
Simmer20 May. 30 at 10:00 PM
$RAFA Compete Scam
1 · Reply
pa600a
pa600a May. 29 at 12:23 PM
$RAFA
1 · Reply
Nanoman1
Nanoman1 May. 14 at 10:42 AM
$RAFA They just filed their management certification and attorney letter for end of 2024 with OTCMarkets. Stock is starting to respond. https://www.otcmarkets.com/stock/RAFA/disclosure
0 · Reply
pa600a
pa600a Apr. 30 at 1:59 PM
$RAFA Topic: RAFArma Time: Apr 30, 2025 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://us06web.zoom.us/j/81166947770?pwd=kR6jJmpYama8DQZbgY5OQPby4PA1IZ.1 Meeting ID: 811 6694 7770 Passcode: 8ieuNi --- One tap mobile +15642172000,,81166947770#,,,,*856462# US +16465588656,,81166947770#,,,,*856462# US (New York) --- Dial by your location • +1 564 217 2000 US • +1 646 558 8656 US (New York) • +1 646 931 3860 US • +1 669 444 9171 US • +1 689 278 1000 US • +1 719 359 4580 US • +1 720 707 2699 US (Denver) • +1 253 205 0468 US • +1 253 215 8782 US (Tacoma) • +1 301 715 8592 US (Washington DC) • +1 305 224 1968 US • +1 309 205 3325 US • +1 312 626 6799 US (Chicago) • +1 346 248 7799 US (Houston) • +1 360 209 5623 US • +1 386 347 5053 US • +1 507 473 4847 US Meeting ID: 811 6694 7770 Passcode: 856462 Find your local number: https://us06web.zoom.us/u/kkl0XK1F4
0 · Reply
pa600a
pa600a Apr. 25 at 4:10 AM
$RAFA .071 close and the future market cap of roughly $2 billion once the company restructuring has been completed. Previous estimate December 2025 from management. Stay tuned!
0 · Reply
Nanoman1
Nanoman1 Mar. 14 at 1:37 AM
$RAFA Presentation Slides from Virtual Conference 3/13/2025 https://on24static.akamaized.net/event/48/96/44/2/rt/1/documents/resourceList1741808535823/rafarmapharmaceuticals20251741808535823.pdf
1 · Reply
pa600a
pa600a Mar. 12 at 8:12 PM
$RAFA https://finance.yahoo.com/news/rafarma-pharmaceuticals-present-virtual-life-152300520.html
0 · Reply
Nanoman1
Nanoman1 Mar. 12 at 7:50 PM
$RAFA Life Sciences Investor Forum Agenda Announced for March 13th Press Release | 03/12/2025 NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum March 13th. This event is co-hosted by Zacks Small Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/4hnure6 https://www.otcmarkets.com/stock/RAFA/news?id=470330
0 · Reply
pa600a
pa600a Mar. 1 at 4:54 PM
$RAFA 3. New Enterprise in Uzbekistan: We are also planning to establish a new enterprise in Uzbekistan, where we will hold a 51% stake. We have redefined the project to align with local market realities and enhance export potential. This initiative focuses on the production of psychotherapeutic agents, and we anticipate significant progress by the end of March. 4. Audit and Financial Transparency: It is important to note that until the restructuring is finalized and the new assets are incorporated, our consolidated PCAOB audit will not reflect these changes. We are currently conducting an audit for the years 2023-2024, which will address the withdrawal of Russian assets and the integration of our international assets. The audit for 2025 will then present the new assets outlined above.
0 · Reply
pa600a
pa600a Mar. 1 at 4:50 PM
$RAFA Dear Shareholders, As the Chairman of the Board of Directors of Rafarma, I am pleased to present our comprehensive action plan aimed at the strategic development of our company in light of the current geopolitical landscape. We will be establishing a robust operational base in Hong Kong and Kazakhstan to navigate these changes effectively. Our management team has decided to implement a restructuring of the company, which will include the introduction of several innovative projects: 1. Establishment of a Subsidiary in Kazakhstan: We are excited to announce the creation of a subsidiary that will collaborate with the Institute of Nuclear Physics in Almaty. This joint venture, involving Bebig, Medline, and Rafarma, will see Rafarma holding a minimum of 70% of the capital. Our primary objective in the upcoming year will be to produce isotopic substances for the pharmacological sector.
0 · Reply
Jofluke2132
Jofluke2132 Feb. 15 at 6:25 PM
$RAFA https://cloud.mail.ru/stock/cVyAeC6JBnF7nYEES5nSM185
0 · Reply
Jofluke2132
Jofluke2132 Feb. 15 at 6:23 AM
$RAFA Dear Shareholders, As the Chairman of the Board of Directors of Rafarma, I am pleased to present our comprehensive action plan aimed at the strategic development of our company in light of the current geopolitical landscape. As previously discussed in our press conferences, it has become essential for us to adapt our operational strategies, focusing on projects and assets that diverge from our original plans. We will be establishing a robust operational base in Hong Kong and Kazakhstan to navigate these changes effectively. Our management team has decided to implement a restructuring of the company, which will include the introduction of several innovative projects: 1. Establishment of a Subsidiary in Kazakhstan: We are excited to announce the creation of a subsidiary that will collaborate with the Institute of Nuclear Physics in Almaty. This joint venture, involving Bebig, Medline, and Rafarma, will see Rafarma holding a minimum of 70% of the capital. Our primary objective
0 · Reply
Jofluke2132
Jofluke2132 Feb. 7 at 11:06 AM
$RAFA Topic: Rafarma Zoom Meeting Time: Feb 10, 2025 12:00 PM Eastern Time (US and Canada) Join Zoom Meeting https://us05web.zoom.us/j/86335845479?pwd=dhK9c53jvGo4KXy5LWMjTAdopkE4NN.1 Meeting ID: 863 3584 5479 Passcode: 3wjKvZ respectfully yours, Liza
0 · Reply
pa600a
pa600a Jan. 17 at 6:03 AM
$RAFA In the long run, it’s the new assets incoming to the Rafa share structure. noyarp.com
0 · Reply
PenkeTrading
PenkeTrading Jan. 14 at 9:20 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Rafarma Pharmaceuticals Inc. Is that bullish or bearish? $RAFA #Rafarma #RsiOverbought #PINK
0 · Reply
pa600a
pa600a Jan. 4 at 5:03 AM
$RAFA 88 watchers on Friday Jan 03 lets see it increase this month.
0 · Reply
pa600a
pa600a Jan. 4 at 4:59 AM
$RAFA Rafarma pharmaceutical updates Press Release | 12/18/2024 Sheridan, Wyoming, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) Dear Rafarma shareholders, We will hold a shareholders meeting before February 1, 2025, to make decisions on reinvesting in the company and changing its capital structure. And we will hold a press conference for you on Zoom after that to share the news we have been preparing since autumn 2024 regarding the company's structure, audit and its new pharmaceutical areas. We need to make a number of changes before March 2025 so that we can please you with facts. The best lawyers and financiers are working with us. Our press attaché Liza Babenko will collect all your questions by that time and we will voice over them at the press conference. Please contact her with questions before that time. Sincerely, Chairman of the Board of Directors of Rafarma Ilya Shpurov
0 · Reply
Nanoman1
Nanoman1 Dec. 18 at 4:29 PM
$RAFA Rafarma pharmaceutical updates Press Release | 12/18/2024 https://www.otcmarkets.com/stock/RAFA/news?id=462739
0 · Reply
pa600a
pa600a Dec. 11 at 10:51 PM
$RAFA https://www.biospace.com/rafarma-to-be-acquired-by-r-and-d-biocogency-laboratories-inc Old news that I just discovered.
0 · Reply
ADCJ
ADCJ Oct. 30 at 8:19 PM
$RAFA Finally coming back up? - news? updates?
0 · Reply